Quanticate partners with KPS Life to build a unique service offering

A new partnership has been formed this month between Quanticate, the global biometric clinical research organisation, and KPS Life, a global functional service provider offering clinical outsourcing solutions to biopharmaceutical and medical device and diagnostic companies. 

The companies will also be able to utilise their collective experience to offer end-to-end solutions for pharma companies. This will provide a boost in biopharma companies’ capabilities to run clinical research projects. 

“We are thrilled to be partnering with KPS Life and offering biotech and pharma companies access to our expert biometric data services alongside KPS Life’s FSP solutions,” commented David Underwood, CEO at Quanticate. 

“By combining our expertise, we will be able to provide an end-to-end solution that delivers high-quality data and comprehensive clinical services to sponsors. This partnership represents a significant milestone for Quanticate and KPS Life, and we look forward to working together to deliver exceptional results for our clients.” 

The partnership comes as a strategic move, to provide a unique, well balanced service for biopharma companies, opening up a lot of doors for these companies so they can take advantage of their respective expertise. 

“Our clients have come to expect high-quality resource solutions and our deep commitment to solving their staffing challenges in this tough labour environment. We are confident that partnering with Quanticate will be a strong addition to our collective service offerings,” stated David Kelly, CEO at KPS Life.  

“This partnership represents an exciting opportunity for Sponsor companies to access a full range of services from two expert organisations. We believe our collaboration will help companies achieve their clinical research goals more efficiently and effectively.”

Source: Quanticate Press Room. Quanticate announces strategic partnership with KPS Life. [Date accessed 06/06/2023]